Have a personal or library account? Click to login

Improvement of long segment ribosomal PCR amplification for molecular identification of Litylenchus crenatae mccannii associated with beech leaf disease

By:
L.K. Carta and  S. Li  
Open Access
|Mar 2020

Figures & Tables

Figure 7:

Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with both DreamTaq™ and Pfu in manufacturer’s PCR buffers. M: DNA markers; 1: 104K29; 2: 104K30; 3: 104K31; NC: negative control, respectively. A: DreamTaq™ PCR buffer; B: Pfu PCR buffer.
Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with both DreamTaq™ and Pfu in manufacturer’s PCR buffers. M: DNA markers; 1: 104K29; 2: 104K30; 3: 104K31; NC: negative control, respectively. A: DreamTaq™ PCR buffer; B: Pfu PCR buffer.

Figure 1:

Long range ribosomal PCR Amplifications of the 3.5 kb target from Fall specimens with DreamTaq™. M: DNA markers; 1: 104H78; 2: 104H81; 3: 104H82; 4: 104H83; 5: 104H84; 6: 104H85; 7: 104H86; 8: 104H87; 9: 104H88; 10: 104H89; 11: 104H90; NC: negative control. 1-7: Female; 8-11: Male.
Long range ribosomal PCR Amplifications of the 3.5 kb target from Fall specimens with DreamTaq™. M: DNA markers; 1: 104H78; 2: 104H81; 3: 104H82; 4: 104H83; 5: 104H84; 6: 104H85; 7: 104H86; 8: 104H87; 9: 104H88; 10: 104H89; 11: 104H90; NC: negative control. 1-7: Female; 8-11: Male.

Figure 2:

Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with TaKaRa Ex Taq® system. M: DNA markers; 1: 104J54; 2: 104J55; 3: 104J58; 4: 104J59; NC: negative control, respectively. A: DreamTaq™; B: 18 S locus (1.7 kb) by DreamTaq™, C: ITS and 28 S loci (1.9 kb) by DreamTaq™; D: TaKaRa Ex Taq® system.
Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with TaKaRa Ex Taq® system. M: DNA markers; 1: 104J54; 2: 104J55; 3: 104J58; 4: 104J59; NC: negative control, respectively. A: DreamTaq™; B: 18 S locus (1.7 kb) by DreamTaq™, C: ITS and 28 S loci (1.9 kb) by DreamTaq™; D: TaKaRa Ex Taq® system.

Figure 3:

Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K17; 2: 104K18; 3: 104K19; 4: 104K20; NC: negative control, respectively. A: DreamTaq™; B: PicoMaxx™ High Fidelity PCR System.
Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K17; 2: 104K18; 3: 104K19; 4: 104K20; NC: negative control, respectively. A: DreamTaq™; B: PicoMaxx™ High Fidelity PCR System.

Figure 4:

Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K25; 2: 104K26; 3: 104K27; 4: 104K28; 5: 104K29; 6: 104K30; 7: 104K31; NC: negative control, respectively. A: DreamTaq™; B: PicoMaxx™ High Fidelity PCR System.
Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K25; 2: 104K26; 3: 104K27; 4: 104K28; 5: 104K29; 6: 104K30; 7: 104K31; NC: negative control, respectively. A: DreamTaq™; B: PicoMaxx™ High Fidelity PCR System.

Figure 9:

PCR performance of TaKaRa Ex Taq® system and PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1 and 5: 104K37; 2 and 6: 104K38; 3 and 7: 104K39; 4 and 8: 104K40. A: 1, 2, 3 and 4: TaKaRa Ex Taq® system; 5, 6, 7 and 8: PicoMaxx™ High Fidelity PCR System; B: 1, 2, 3 and 4: TaKaRa Ex Taq® system and DreamTaq™; 5, 6, 7 and 8: PicoMaxx™ High Fidelity PCR System. NC: negative control, respectively.
PCR performance of TaKaRa Ex Taq® system and PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1 and 5: 104K37; 2 and 6: 104K38; 3 and 7: 104K39; 4 and 8: 104K40. A: 1, 2, 3 and 4: TaKaRa Ex Taq® system; 5, 6, 7 and 8: PicoMaxx™ High Fidelity PCR System; B: 1, 2, 3 and 4: TaKaRa Ex Taq® system and DreamTaq™; 5, 6, 7 and 8: PicoMaxx™ High Fidelity PCR System. NC: negative control, respectively.

Figure 5:

Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with DreamTaq™ and PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K25; 2: 104K26; 3: 104K27; 4: 104K28; 5: 104K29; 6: 104K30; 7: 104K31; NC: negative control, respectively. A: 18 S locus (1.7 kb) by DreamTaq™, B: ITS and 28 S loci (1.9 kb) by DreamTaq™; C: DreamTaq™ and PicoMaxx™ High Fidelity PCR System combined.
Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with DreamTaq™ and PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K25; 2: 104K26; 3: 104K27; 4: 104K28; 5: 104K29; 6: 104K30; 7: 104K31; NC: negative control, respectively. A: 18 S locus (1.7 kb) by DreamTaq™, B: ITS and 28 S loci (1.9 kb) by DreamTaq™; C: DreamTaq™ and PicoMaxx™ High Fidelity PCR System combined.

Figure 6:

Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with DreamTaq™ or/and Pfu in PicoMaxx™ buffer. M: DNA markers; 1, 2, 3 and 4: DreamTaq™; 5, 6, 7 and 8: Pfu; 9, 10, 11and 12: DreamTaq™ and Pfu combined; 1, 5 and 9: 104K29; 2, 6 and 10: 104K30; 3, 7 and 11: 104K31; 4, 8 and 12: negative control (NC), respectively.
Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with DreamTaq™ or/and Pfu in PicoMaxx™ buffer. M: DNA markers; 1, 2, 3 and 4: DreamTaq™; 5, 6, 7 and 8: Pfu; 9, 10, 11and 12: DreamTaq™ and Pfu combined; 1, 5 and 9: 104K29; 2, 6 and 10: 104K30; 3, 7 and 11: 104K31; 4, 8 and 12: negative control (NC), respectively.

Figure 8:

PCR performance of Pfu and Pwo in PicoMaxx™ buffer. M: DNA markers; 1 and 4: 104K37; 2 and 5: 104K38; 3 and 6: 104K39. A: 1, 2 and 3: DreamTaq™; 4, 5 and 6: Pwo (0.125 μl per reaction). B: 1, 2 and 3: DreamTaq™ and Pfu; 4, 5 and 6: DreamTaq™ and Pwo (0.125 μl per reaction). NC: negative control, respectively. Note: final concentration of Pfu in each reaction was aligned with Pwo and DreamTaq™ in 0.625 units.
PCR performance of Pfu and Pwo in PicoMaxx™ buffer. M: DNA markers; 1 and 4: 104K37; 2 and 5: 104K38; 3 and 6: 104K39. A: 1, 2 and 3: DreamTaq™; 4, 5 and 6: Pwo (0.125 μl per reaction). B: 1, 2 and 3: DreamTaq™ and Pfu; 4, 5 and 6: DreamTaq™ and Pwo (0.125 μl per reaction). NC: negative control, respectively. Note: final concentration of Pfu in each reaction was aligned with Pwo and DreamTaq™ in 0.625 units.

Figure 10:

PCR performance of Herculase® II Fusion DNA polymerase and Phusion™ High-Fidelity DNA Polymerase. M: DNA markers; 1 and 5: 104K37; 2 and 6: 104K38; 3 and 7: 104K39; 4 and 8: 104K40. 1, 2, 3 and 4: Herculase® II Fusion DNA polymerase; 5, 6, 7 and 8: Phusion™ High Fidelity PCR System; NC: negative control, respectively.
PCR performance of Herculase® II Fusion DNA polymerase and Phusion™ High-Fidelity DNA Polymerase. M: DNA markers; 1 and 5: 104K37; 2 and 6: 104K38; 3 and 7: 104K39; 4 and 8: 104K40. 1, 2, 3 and 4: Herculase® II Fusion DNA polymerase; 5, 6, 7 and 8: Phusion™ High Fidelity PCR System; NC: negative control, respectively.

Figure 11:

PCR performance of Taq2000™, Platinum™ Taq and DreamTaq™. M: DNA markers; 1, 4 and 7: 104N95; 2, 5 and 8: 104N96; 3, 6 and 9: 104N97. 1, 2, 3 and NC by Taq2000™; 4, 5, 6 and NC by Platinum™ Taq; 7, 8, 9 and NC by DreamTaq™, NC: negative control, respectively. A: 3.5 kb target; B: 1.9 kb ITS and 28 S target. Note: final concentration of either Taq2000™ or DreamTaq™ in each reaction was aligned with Platinum™ Taq in 1.25 units.
PCR performance of Taq2000™, Platinum™ Taq and DreamTaq™. M: DNA markers; 1, 4 and 7: 104N95; 2, 5 and 8: 104N96; 3, 6 and 9: 104N97. 1, 2, 3 and NC by Taq2000™; 4, 5, 6 and NC by Platinum™ Taq; 7, 8, 9 and NC by DreamTaq™, NC: negative control, respectively. A: 3.5 kb target; B: 1.9 kb ITS and 28 S target. Note: final concentration of either Taq2000™ or DreamTaq™ in each reaction was aligned with Platinum™ Taq in 1.25 units.

Summary of PCR performance of blended DNA polymerases (systems) tested in this study_

TaKaRa Ex Taq™ combined with DreamTaq™ in TaKaRa Ex bufferPicoMaxx™ System combined with DreamTaq™ in PicoMaxx™ bufferDreamTaq™ in PicoMaxx™ buffer pfu in PicoMaxx™ buffer Pfu combined with DreamTaq™ in PicoMaxx™ buffer pfu combined with DreamTaq™ in DreamTaq™ buffer pfu combined with DreamTaq™ in pfu buffer Pwo in PicoMaxx™ buffer Pwo combined with DreamTaq™ in Pwo buffer Pwo combined with DreamTaq™ in PicoMaxx buffer
Spring specimensnananananananananana
Summer specimens3.5 kb: X3.5 kb: √√√/X3.5 kb: √/X or X3.5 kb: X3.5 kb: √√√√ or √√3.5 kb: X3.5 kb: X3.5 kb: X3.5 kb: X (DNS)3.5 kb: √/X
Fall specimensnananananananananana

Summary of PCR performance of Individual DNA polymerases (systems) tested in this study_

Platinum™ Taq Taq2000™DreamTaqTaKaRa Ex TaqPicoMaxx™ System pfu Pwo Herculase® IIPhusion™
Spring specimens3.5 kb: X; 1.9 kb: √/X3.5 kb: X; 1.9 kb: √√√√/X3.5 kb: X; 1.9 kb: √√√√nananananana
Summer specimensna3.5 kb: X (DNS); 1.9 kb: √√√ (DNS)3.5 kb: X or X/√ (DNS); 1.7Kb: √√√√/X; 1.9 kb: √√√√/X3.5 kb: √√/X or X3.5 kb: √√/X or X3.5 kb: X (DNS)3.5 kb: X (DNS)3.5 kb: X3.5 kb: X
Fall specimensnana3.5 kb: √√√/X; 1.9 kb: NAnananananana

Litylenchus crenatae specimens from American beech trees (Fagus grandifolia) with BLD tested in this study_

SpecimensLocalityPartSession
104H78, 104H81, 104H82, 104H83, 104H84, 104H85, 104H86, 104H87, 104H88, 104H89 and 104H90Lake County, OhioLeafFall (November, 2017)
104J54, 104J55, 104J56 and 104J57Cuyahoga County, OhioLeafSummer (May, 2018)
104K17, 104K18, 104K19 and 104K20The Holden Arboretum, Kirtland, OhioLeafSummer (August, 2018)
104K25, 104K26, 104K27, 104K28, 104K29, 104K30 and 104K31Potter County, PennsylvaniaLeafSummer (August, 2018)
104K37, 104K38 and 104K39Crawford County, PennsylvaniaLeafSummer (August, 2018)
104N95, 104N96 and 104N97The Holden Arboretum, Kirtland, OhioBudSpring (March, 2019)

PCR cycling conditions_

No. Step pfu or combined with DreamTaqHerculase® IIPhusion™ Pwo or combined with DreamTaq
1. Initial denaturation95°C for 2 minStep 1: 1 cycle95°C for 2 minStep 1: 1 cycle95°C for 2 minStep 1: 1 cycle95°C for 2 minStep 1: 1 cycle
2. Denaturation95°C for 30 secStep 2, 3 and 4: 36 cycles95°C for 20 secStep 2, 3 and 4: 36 cycles95°C for 20 secStep 2, 3 and 4: 36 cycles95°C for 30 secStep 2, 3 and 4: 36 cycles
3. Annealling55°C for 45 sec 55°C for 20 sec 55°C for 20 sec 57°C for 45 sec
4. Extension72°C for 5 min 72°C for 2 min 15 sec 72°C for 2 min 15 sec 72°C for 5 min
5. Final extension72°C for 7 minStep 5: 1 cycle72°C for 7 minStep 5: 1 cycle72°C for 7 minStep 5: 1 cycle72°C for 7 minStep 5: 1 cycle

PCR components and setup_

Platinum™ Taq (10 units/μl) Taq2000™ (5 units/μl)DreamTaq™ (5 units/μl)TaKaRa Ex Taq™ (5 units/μl) or combined with DreamTaq™ (5 units/μl)PicoMaxx™ System (5 units/μl) or combined with DreamTaq™ (5 units/μl) pfu DNA polymerase (2.5 units/μl) or combined with DreamTaq™ (5 units/μl)Herculase® II Fusion DNA polymerasePhusion™ High-Fidelity DNA Polymerase (2 units/μl) Pwo DNA polymerase (5 units/μl) or combined with DreamTaq™ (5 units/μl)
Water (μl) Mixture A: 7.6
Water (μl)15.3751616.375/16.2515.875 or 15.7517.3 or 17.17517.05/17.55 or 16.925/17.4251614.5Mixture B: 9.875 (or 9.75)
10 or 5x proprietary buffer (μl)2.52.52.52.52.52.555Mixture A: 2.5
50 mM MgCl2 (μl)10.25
100 mM dNTP (25 mM each) (μl) 0.20.20.25 Mixture B: 0.4
10 mM dNTP (2.5 mM each) (μl) 2 0.5
8 mM dNTP (2 mM each) (μl)2.52.52.5
10 μm Forward primer (μl)0.750.750.751.251.251.250.6251.25Mixture B: 1.25
10 μm Reverse primer (μl)0.750.750.751.251.251.250.6251.25Mixture B: 1.25
DMSO 0.25
DNA template (μl)22222222Mixture B: 2
Proprietary DNA polymerase(s) (μl)0.1250.250.125/0.250.125 or plus DreamTaq™: 0.1250.5 or plus DreamTaq™: 0.1250.75/0.25 or plus DreamTaq™: 0.1250.50.25Mixture A: 0.125 or plus DreamTaq™: 0.125
Total reaction volume (μl)252525252525252512.5 each mixture
DOI: https://doi.org/10.21307/jofnem-2020-016 | Journal eISSN: 2640-396X | Journal ISSN: 0022-300X
Language: English
Page range: 1 - 15
Submitted on: Sep 30, 2019
Published on: Mar 17, 2020
Published by: Society of Nematologists, Inc.
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 L.K. Carta, S. Li, published by Society of Nematologists, Inc.
This work is licensed under the Creative Commons Attribution 4.0 License.